Tumor‐specific peptides in cutaneous T‐cell lymphoma: Association with class I major histocompatibility complex and possible derivation from the clonotypic T‐cell receptor
Berger C, Longley B, Imaeda S, Christensen I, Heald P, Edelson R. Tumor‐specific peptides in cutaneous T‐cell lymphoma: Association with class I major histocompatibility complex and possible derivation from the clonotypic T‐cell receptor. International Journal Of Cancer 1998, 76: 304-311. PMID: 9579563, DOI: 10.1002/(sici)1097-0215(19980504)76:3<304::aid-ijc3>3.0.co;2-z.Peer-Reviewed Original ResearchMeSH KeywordsAmino Acid SequenceAntigens, NeoplasmCD8-Positive T-LymphocytesGenes, T-Cell Receptor betaHistocompatibility Antigens Class IHumansLymphoma, T-Cell, CutaneousMolecular Sequence DataPeptidesProtein ConformationSequence AlignmentSequence Homology, Amino AcidSkin NeoplasmsT-Lymphocyte SubsetsT-Lymphocytes, CytotoxicTumor Necrosis Factor-alphaConceptsCutaneous T-cell lymphomaT cell receptorClonotypic T cell receptorIdiotypic peptideT-cell lymphomaCD8 cellsClass I moleculesCTCL patientsClass I peptidesTumor cellsClass II moleculesAnti-tumor vaccinesClass I major histocompatibilityMalignant T cellsCTCL tumor cellsTumor-specific peptidesI peptidesTNF-alpha assayCD8 responsesNovel class IPeptide-binding motifTumor necrosisT cellsCTCL cells